About Cypher Genomics
Cypher Genomics is a company based in San Diego (United States) founded in 2011 was acquired by Human Longevity in November 2015. It operates as a Professional Services. The company has 83 employees as of December 31, 2022. Cypher Genomics offers products and services including Mantis Genomic Coral Biomarker Array Chip and qPCR Assay. Cypher Genomics operates in a competitive market with competitors including GSK, DNAnexus, Avidity Biosciences, Sutro Biopharma and Antheia, among others.
- Headquarter San Diego, United States
- Employees 83 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Human Longevity, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Human Longevity
& 2 more
-
Employee Count
83
as on Dec 31, 2022
-
Acquired by
Human Longevity
(Nov 30, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cypher Genomics
Cypher Genomics offers a comprehensive portfolio of products and services, including Mantis Genomic Coral Biomarker Array Chip and qPCR Assay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Used for detecting biomarkers in genomic research assays.
Employed for precise quantification of genetic material samples.
Unlock access to complete
Funding Insights of Cypher Genomics
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Seed - Cypher Genomics | Valuation |
investors |
|
| Jul, 2014 | Amount | Seed - Cypher Genomics | Valuation | EvoNexus |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cypher Genomics
Cypher Genomics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Human Longevity, Three Leaf Ventures and EvoNexus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage centric sector-agnostic venture capital firm funding companies in the US
|
Founded Year | Domain | Location | |
|
12-18 month incubation programs are provided for startups in California.
|
Founded Year | Domain | Location | |
|
Genomics data and cell therapy-based diagnostic and therapeutic solutions
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cypher Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cypher Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cypher Genomics Comparisons
Competitors of Cypher Genomics
Cypher Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, DNAnexus, Avidity Biosciences, Sutro Biopharma and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cypher Genomics
When was Cypher Genomics founded?
Cypher Genomics was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Where is Cypher Genomics located?
Cypher Genomics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
How many employees does Cypher Genomics have?
As of Dec 31, 2022, the latest employee count at Cypher Genomics is 83.
What does Cypher Genomics do?
Cypher Genomics is involved in the development of genomic diagnostic tools and assays. The company focuses on solutions like the Mantis Genomic Coral Biomarker Array Chip and qPCR assays, targeting the biotechnology sector. Its offerings are utilized in research for detecting biomarkers, proteins, and molecules associated with various conditions. The company also provides resources and references for lab reagents and antibodies through its platform.
Who are the top competitors of Cypher Genomics?
Cypher Genomics's top competitors include DNAnexus, Sutro Biopharma and Synthego.
What products or services does Cypher Genomics offer?
Cypher Genomics offers Mantis Genomic Coral Biomarker Array Chip and qPCR Assay.
Who are Cypher Genomics's investors?
Cypher Genomics has 3 investors. Key investors include Human Longevity, Three Leaf Ventures, and EvoNexus.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.